Rapid responses are electronic letters to the editor. They enable our users to debate issues raised in articles published on thebmj.com. Although a selection of rapid responses will be included online and in print as readers' letters, their first appearance online means that they are published articles. If you need the url (web address) of an individual response, perhaps for citation purposes, simply click on the response headline and copy the url from the browser window. Letters are indexed in PubMed.
Given the fact that the marketing authorisation for valsartan in
Austria dates from December 1996 and is probably similar in the UK, the
title does not strike me as particularly apt. Also, would it not have been
simpler to say that valsartan was no more effective than captopril?
A. Bucsics works for the Main Association of Austrian Health Insurance Institutions, which pay for both valsartan and captopril